-----BEGIN PRIVACY-ENHANCED MESSAGE----- Proc-Type: 2001,MIC-CLEAR Originator-Name: webmaster@www.sec.gov Originator-Key-Asymmetric: MFgwCgYEVQgBAQICAf8DSgAwRwJAW2sNKK9AVtBzYZmr6aGjlWyK3XmZv3dTINen TWSM7vrzLADbmYQaionwg5sDW3P6oaM5D3tdezXMm7z1T+B+twIDAQAB MIC-Info: RSA-MD5,RSA, NBCyfdkAfWEHIdeinGSUBQ2viJpbgAUxMsluBHq70dfX2NixWyXzTQ3LI7YFyriP mt3Nq5mDhlVp1D8n5HF/fQ== 0001104659-10-059176.txt : 20101118 0001104659-10-059176.hdr.sgml : 20101118 20101118165444 ACCESSION NUMBER: 0001104659-10-059176 CONFORMED SUBMISSION TYPE: 8-K PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20101117 ITEM INFORMATION: Regulation FD Disclosure FILED AS OF DATE: 20101118 DATE AS OF CHANGE: 20101118 FILER: COMPANY DATA: COMPANY CONFORMED NAME: ARTHROCARE CORP CENTRAL INDEX KEY: 0001005010 STANDARD INDUSTRIAL CLASSIFICATION: ELECTROMEDICAL & ELECTROTHERAPEUTIC APPARATUS [3845] IRS NUMBER: 943180312 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K SEC ACT: 1934 Act SEC FILE NUMBER: 001-34607 FILM NUMBER: 101203286 BUSINESS ADDRESS: STREET 1: 7500 RIALTO BOULEVARD STREET 2: BUILDING TWO, SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78735 BUSINESS PHONE: (512) 391-3900 MAIL ADDRESS: STREET 1: 7500 RIALTO BOULEVARD STREET 2: BUILDING TWO, SUITE 100 CITY: AUSTIN STATE: TX ZIP: 78735 8-K 1 a10-21566_18k.htm CURRENT REPORT OF MATERIAL EVENTS OR CORPORATE CHANGES

 

 

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

WASHINGTON, D.C. 20549

 

 

FORM 8-K

 

CURRENT REPORT

Pursuant to Section 13 or 15(d) of the

Securities Exchange Act of 1934

 

Date of Report (Date of earliest event reported): November 17, 2010

 

ARTHROCARE CORPORATION

(Exact name of registrant as specified in its charter)

 

Delaware

(State or other jurisdiction
of Incorporation)

 

0-027422

(Commission File Number)

 

94-3180312

(I.R.S. Employer Identification
Number)

 

7500 Rialto Blvd., Building Two, Suite 100

Austin, TX  78735

(Address of principal executive offices, including zip code)

 

(512) 391-3900

(Registrant’s telephone number, including area code)

 

Not Applicable

(Former name or former address, if changed since last report)

 

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2 below):

 

o  Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

 

o  Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

 

o  Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

 

o  Pre-commencement communications pursuant to Rule 14e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

 

 

 


 

Item 7.01 — Regulation FD Disclosure

 

On November 17, 2010, Sten I. Dahlborg, Senior Vice President of International Operations, entered into a prearranged trading plan to sell 13,733 shares in one or more open market transactions between December 16, 2010 and November 20, 2011.

 

Rule 10b5-1 permits persons who may be considered company insiders to establish written prearranged stock trading plans when they are not in possession of material, nonpublic information. The plans establish predetermined trading parameters that do not permit the person adopting the plan to exercise any subsequent influence over how, when or whether to effect trades. All sales under the plans will be disclosed publicly through appropriate filings with the U.S. Securities and Exchange Commission.

 

2


 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, as amended, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.

 

 

ARTHROCARE CORPORATION

 

 

 

Date: November 18, 2010

By:

/s/ Todd Newton

 

Todd Newton

 

Senior Vice President and Chief Financial Officer

 

3

 -----END PRIVACY-ENHANCED MESSAGE-----